Crispin J. Miller
Garscube Estate, Switchback Road
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.
Journal: British journal of cancer
Published: April 10, 2025
PLM-interact: extending protein language models to predict protein-protein interactions.
Journal: Nature communications
Published: December 11, 2024
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.
Journal: Nature
Published: December 10, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Journal: Nature genetics
Published: June 03, 2024
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.
Journal: Nature genetics
Published: February 08, 2024
Hepatic zonation determines tumorigenic potential of mutant β-catenin.
Journal: Nature
Published: May 19, 2023
Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function.
Journal: Science advances
Published: February 03, 2023
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Journal: Nature genetics
Published: December 04, 2022
Author Correction: Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix.
Journal: Nature metabolism
Published: August 04, 2022
Human-correlated genetic models identify precision therapy for liver cancer.
Journal: Nature
Published: May 09, 2022
Last Updated: 09/26/2026